Hepatitis C virus (HCV) infection disparities by sex are typically consistent across the US; however, race differences in HCV infection differ by state, a recent study found. Researchers used 3 data sources to estimate HCV RNA prevalence in the US among noninstitutionalized adults stratified by sex and race group. They found:
- Nationally, males had an estimated HCV RNA prevalence of 1.56% and females had a prevalence of 0.75%.
- Stratified by race, national estimated prevalence of HCV RNA was highest among non-Hispanic black, followed by non-Hispanic white, and Hispanic/other.
- Males in most jurisdictions had an HCV RNA prevalence that is between 1.5 and 2.5 times higher than females.
Hall EW, Rosenberg ES, Sullivan PS. Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. [Published online ahead of print May 16, 2018]. BMC Infect Dis. doi:10.1186/s12879-018-3133-6.
Must Reads in Hepatitis
Glecaprevir/Pibrentasvir Efficacy & Safety Assessed, J Hepatol; ePub 2018 Nov 23; D’Ambrosio, et al
HCV Infection Among Children & Young Persons, J Hepatol; ePub 2018 Nov 26; Modin, et al
HCV Patients with Limited Access to Antiviral Therapy, Dig Liver Dis; ePub 2018 Nov 29; Lens, et al
Progression in the Elimination of HCV Infection, PLoS One; ePub 2018 Dec 4; Juanbeltz, et al
Increased HCV Screening in Veteran Populations, Jt Comm J Qual Patient Saf; ePub 2018 Sep 25; Wray, et al